World's first artificial human platelet lysate

BioScience Raises the Bar in Cell Culture Technology with artificial HPL

13-May-2025
Computer-generated image

Symbolic image

PL BioScience GmbH, a German life science company specializing in the production and development of Human platelet lysate (HPL) for cell expansion, announced the first-ever production of an artificial HPL cell culture solution. In partnership with the Korean biotech DewCell Biotherapeutics (DewCell), the first company to generate artificial platelets from stem cells in a reactor, PL BioScience has developed a proprietary method to transform these lab-grown platelets into a powerful cell culture supplement. Produced in Germany with raw material from DewCell, this new technology offers a scalable, safe, and animal-free alternative to Fetal Calf/Bovine Serum (FCS/FBS) and donor-derived, natural HPL for regenerative medicine, cell therapy, and biopharma applications. A patent for the process has been filed.

“Cell culture innovation is crucial for advancing modern medicine, drug discovery, and understanding complex biological systems,” said Dr. Hatim Hemeda, Chief Executive Officer of PL BioScience. “We are proud to contribute to the field with the very first, scalable artificial HPL solution that, in the mid-term, can be produced in a nearly unlimited supply to meet the growing biopharmaceutical industry needs.”

“We are confident that the combination of DewCell's innovative technology and our cell culture expertise will usher in a new era in the field of regenerative medicine and cell therapy manufacturing,” he added.

HPL is a safe, high-performance cell culture supplement that can be used as an alternative to FBS/FCS. HPL is manufactured from donated human blood platelets that are outdated and no longer safe for transfusion, making them a sustainable but limited source to produce HPL. With its proprietary technology for the synthetic production of HPL in conjunction with DewCell’s artificial platelet technology, PL BioScience can overcome this limitation and provides a fully scalable, high-performing cell culture supplement for biopharmaceutical applications.

Other news from the department business & finance

Most read news

More news from our other portals

Something is happening in the life science industry ...

This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.